tolvaptan 7.5mg/day (can be escalated to 15mg, if needed)
Sponsors
Social Insurance Yokohama Central Hospital, Fujisawa City Hospital
Conditions
End stage renal disease , heart failureHeart Failure
Unknown Phase
A clinical study to investigate the efficacy of diuretics to the HF patients with proteinuria and edema.
RecruitingJPRN-UMIN000006212
Start: 2011-08-01Target: 15Updated: 2026-06-29
A study to evaluate the efficacy and safety of Tolvaptan in heart failure patients with peritoneal dialysis
Active, not recruitingJPRN-UMIN000009228
Start: 2012-10-08Target: 20Updated: 2026-06-29